263 related articles for article (PubMed ID: 26530501)
1. Pharmacokinetics, pharmacodynamics and toxicology of new psychoactive substances (NPS): 2C-B, 4-fluoroamphetamine and benzofurans.
Nugteren-van Lonkhuyzen JJ; van Riel AJ; Brunt TM; Hondebrink L
Drug Alcohol Depend; 2015 Dec; 157():18-27. PubMed ID: 26530501
[TBL] [Abstract][Full Text] [Related]
2. Monitoring new psychoactive substances (NPS) in The Netherlands: data from the drug market and the Poisons Information Centre.
Hondebrink L; Nugteren-van Lonkhuyzen JJ; Van Der Gouwe D; Brunt TM
Drug Alcohol Depend; 2015 Feb; 147():109-15. PubMed ID: 25541244
[TBL] [Abstract][Full Text] [Related]
3. Purity, adulteration and price of drugs bought on-line versus off-line in the Netherlands.
van der Gouwe D; Brunt TM; van Laar M; van der Pol P
Addiction; 2017 Apr; 112(4):640-648. PubMed ID: 27936283
[TBL] [Abstract][Full Text] [Related]
4. The psychoactive aminoalkylbenzofuran derivatives, 5-APB and 6-APB, mimic the effects of 3,4-methylenedioxyamphetamine (MDA) on monoamine transmission in male rats.
Brandt SD; Walters HM; Partilla JS; Blough BE; Kavanagh PV; Baumann MH
Psychopharmacology (Berl); 2020 Dec; 237(12):3703-3714. PubMed ID: 32875347
[TBL] [Abstract][Full Text] [Related]
5. Novel Phenethylamines and Their Potential Interactions With Prescription Drugs: A Systematic Critical Review.
Inan F; Brunt TM; Contrucci RR; Hondebrink L; Franssen EJF
Ther Drug Monit; 2020 Apr; 42(2):271-281. PubMed ID: 32022784
[TBL] [Abstract][Full Text] [Related]
6. Next generation of novel psychoactive substances on the horizon - A complex problem to face.
Zawilska JB; Andrzejczak D
Drug Alcohol Depend; 2015 Dec; 157():1-17. PubMed ID: 26482089
[TBL] [Abstract][Full Text] [Related]
7. Effect fingerprinting of new psychoactive substances (NPS): What can we learn from in vitro data?
Hondebrink L; Zwartsen A; Westerink RHS
Pharmacol Ther; 2018 Feb; 182():193-224. PubMed ID: 29097307
[TBL] [Abstract][Full Text] [Related]
8. Metabolic fate, mass spectral fragmentation, detectability, and differentiation in urine of the benzofuran designer drugs 6-APB and 6-MAPB in comparison to their 5-isomers using GC-MS and LC-(HR)-MS(n) techniques.
Welter J; Brandt SD; Kavanagh P; Meyer MR; Maurer HH
Anal Bioanal Chem; 2015 May; 407(12):3457-70. PubMed ID: 25711990
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances.
Simmler LD; Liechti ME
Handb Exp Pharmacol; 2018; 252():143-164. PubMed ID: 29633178
[TBL] [Abstract][Full Text] [Related]
10. 4-Fluoroamphetamine in the Netherlands: more than a one-night stand.
Linsen F; Koning RP; van Laar M; Niesink RJ; Koeter MW; Brunt TM
Addiction; 2015 Jul; 110(7):1138-43. PubMed ID: 25808511
[TBL] [Abstract][Full Text] [Related]
11. Intoxication caused by new psychostimulants: analytical methods to disclose acute and chronic use of benzofurans and ethylphenidate.
Barceló B; Gomila I; Rotolo MC; Marchei E; Kyriakou C; Pichini S; Roset C; Elorza MÁ; Busardò FP
Int J Legal Med; 2017 Nov; 131(6):1543-1553. PubMed ID: 28710651
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of new psychoactive substances in biological material - a three-year review of casework in Poland.
Adamowicz P; Gieroń J; Gil D; Lechowicz W; Skulska A; Tokarczyk B
Drug Test Anal; 2016 Jan; 8(1):63-70. PubMed ID: 26666629
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological profile of novel psychoactive benzofurans.
Rickli A; Kopf S; Hoener MC; Liechti ME
Br J Pharmacol; 2015 Jul; 172(13):3412-25. PubMed ID: 25765500
[TBL] [Abstract][Full Text] [Related]
14. 4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects.
Caudevilla-Gálligo F; Riba J; Ventura M; González D; Farré M; Barbanoj MJ; Bouso JC
J Psychopharmacol; 2012 Jul; 26(7):1026-35. PubMed ID: 22234927
[TBL] [Abstract][Full Text] [Related]
15. A snapshot on NPS in Italy: Distribution of drugs in seized materials analysed in an Italian forensic laboratory in the period 2013-2015.
Odoardi S; Romolo FS; Strano-Rossi S
Forensic Sci Int; 2016 Aug; 265():116-20. PubMed ID: 26874736
[TBL] [Abstract][Full Text] [Related]
16. New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon?
Giné CV; Espinosa IF; Vilamala MV
Drug Test Anal; 2014; 6(7-8):819-24. PubMed ID: 24470121
[TBL] [Abstract][Full Text] [Related]
17. Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of 'legal high' packages containing synthetic cathinones.
Araújo AM; Valente MJ; Carvalho M; Dias da Silva D; Gaspar H; Carvalho F; de Lourdes Bastos M; Guedes de Pinho P
Arch Toxicol; 2015 May; 89(5):757-71. PubMed ID: 24903018
[TBL] [Abstract][Full Text] [Related]
18. Measuring inhibition of monoamine reuptake transporters by new psychoactive substances (NPS) in real-time using a high-throughput, fluorescence-based assay.
Zwartsen A; Verboven AHA; van Kleef RGDM; Wijnolts FMJ; Westerink RHS; Hondebrink L
Toxicol In Vitro; 2017 Dec; 45(Pt 1):60-71. PubMed ID: 28506818
[TBL] [Abstract][Full Text] [Related]
19. Current European data collection on emergency department presentations with acute recreational drug toxicity: gaps and national variations.
Heyerdahl F; Hovda KE; Giraudon I; Yates C; Dines AM; Sedefov R; Wood DM; Dargan PI
Clin Toxicol (Phila); 2014 Dec; 52(10):1005-12. PubMed ID: 25361166
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology and Literature Review Based on Related Death and Non-Fatal Case Reports of the Benzofurans and Benzodifurans Designer Drugs.
Barcelo B; Gomila I
Curr Pharm Des; 2017; 23(36):5523-5529. PubMed ID: 28714411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
